Log in

GALD Galderma Group AG SIX · Switzerland

Galderma Group (GALD) news

Galderma Group AG is a public biotech or pharmaceutical company listed on SIX under the ticker GALD, recorded under Switzerland. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Galderma Group news

We have not published a story on Galderma Group yet. When there is news, it will appear here.

Questions about Galderma Group

What is the ticker symbol of Galderma Group?

Galderma Group AG trades under the ticker GALD on SIX.

Where is Galderma Group listed?

Galderma Group AG is listed on SIX. Our directory also records these other listings: BMV:GALD/N; BX:GALD; DUS:PY3; FWB:PY3; GETTEX:PY3; HAM:PY3; HAN:PY3; LS:A407X6; LSX:A407X6; MUN:PY3; OTC:GALDY; OTC:GDERF; SWB:PY3; TRADEGATE:PY3; VIE:GALD; XETR:PY3.

What is the SEC CIK of Galderma Group?

The SEC Central Index Key (CIK) for Galderma Group AG is 2021390. Its filings are on SEC EDGAR.

Which country or territory is Galderma Group listed under?

Our directory records Galderma Group AG under Switzerland.

What does Galderma Group do?

Our directory classifies Galderma Group AG as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Galderma Group?

The ISIN recorded for Galderma Group AG is CH1335392721.

Does aibio.space cover Galderma Group?

aibio.space lists Galderma Group AG among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Galderma Group incorporated?

SEC records list its state or country of incorporation as V8.

Where is Galderma Group headquartered?

SEC records list its business address as 383 MADISON AVENUE, NEW YORK, NY, 10179.

When does Galderma Group's fiscal year end?

Galderma Group AG's fiscal year ends on December 31, per SEC records.

Which companies are similar to Galderma Group?

Companies in our directory listed in the same country and business area as Galderma Group: Curatis Holding, Basilea Pharmaceutica, Santhera Pharmaceuticals Holding, ADC Therapeutics SA, Addex Therapeutics, Siegfried Holding.

Investor discussion: Galderma Group

Members talk about Galderma Group (GALD). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Press releases

Headlines of Galderma Group's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. PR Newswire

    Galderma launches ALASTIN Restorative Eye Complex with TriHex+™, bringing new science-backed innovation to the entire eye area

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SIX:GALD on TradingView.

SEC filings and registration

SEC name
Galderma Group AG/ADR
CIK
2021390
US tickers
GALDY (OTC), GDERF (OTC)
State or country of incorporation
V8
Fiscal year ends
December 31
Business address
383 MADISON AVENUE, NEW YORK, NY, 10179
Phone
302-552-0866

Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

Listing details

Galderma Group AG is a public biotech or pharmaceutical company listed on SIX under the ticker GALD, recorded under Switzerland. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Galderma Group AG
Ticker
GALD
Listing
SIX
Country or territory
Switzerland
Business scope
Pharmaceuticals: Major
ISIN
CH1335392721
Other listed symbols
BMV:GALD/N; BX:GALD; DUS:PY3; FWB:PY3; GETTEX:PY3; HAM:PY3; HAN:PY3; LS:A407X6; LSX:A407X6; MUN:PY3; OTC:GALDY; OTC:GDERF; SWB:PY3; TRADEGATE:PY3; VIE:GALD; XETR:PY3
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.